China preps for global vaccine push; BioMarin nabs FDA nod for plant expansion;

@FiercePharma: Supreme Court agrees to hear sales-rep overtime suit. Ruling promises to affect the whole industry-WSJ. News | Follow @FiercePharma

> China is gathering its forces for an assault on the global vaccine market, a move that could lower the cost of shots for poor countries--provided safety fears are assuaged. News

> BioMarin Pharmaceutical has won FDA approval for the expansion of its manufacturing facility in Novato, CA, where it makes Aldurazyme and Naglazyme. Item

> Citi's Yaron Werber lowered his price target on Vertex Pharmaceuticals ($VRTX) to $40 from $59, saying the company will face intense competition for its hepatitis C drug Incivek. Article

> Pozen ($POZN) now looks to a profit for 2011 as $75 million migraine-drug rights sale will be booked as revenue. Story

> The Canadian province of Manitoba has added Pfizer's ($PFE) stop-smoking drug Champix (sold as Chantix in the U.S.) to the health system formulary. More

Biotech News

@FierceBiotech: Onyx Pharma shares soar on report of its hunt for options, acquirers. Story | Follow @FierceBiotech

@RyanMFierce: Roche inked a deal with PTC for Spinal Muscular Atrophy program, $30M upfront and $460M in biobucks. | Follow @RyanMFierce

@MaureenFierce: China prepares for big entry into vaccine market. Will be game-changer if China can alleviate safety concerns. Report | Follow @MaureenFierce

> Onyx Pharma shares soar on report of its hunt for options, acquirers. News

> Roche, PTC strike potential $490M deal for genetic disease program. Article

> 22 drugs to watch in 2012. Report

Research News

> Neuron implants fix broken brain circuitry in obese mice. News

> Combo drug offers potent weapon against radiation exposure. Story

> Princeton research could speed pharma discoveries. More

> New target discovered in battle against lymphoma. Piece

Manufacturing News

> McKesson, J&J eye GHX platform for e-pedigree. Item

> Hospira to spend $375M in manufacturing upgrades. Report

> Europe takes precautions with Ben Venue drugs. News

> Ranbaxy, FDA near $400M deal on longstanding violations. Story

> McKesson, J&J eye GHX platform for e-pedigree. Article

And Finally... Vaccinating children more than a year old against chickenpox offers 'tremendous indirect benefits' to infants, researchers said. Report